Marketplace®
Every story is an economic story

Here’s why Eli Lilly will sell a generic insulin

Lawmakers have been critical of big pharma's pricing structures.

Here’s why Eli Lilly will sell a generic insulin

Indianapolis-based pharmaceutical company Eli Lilly announced Monday that it will sell a generic version of Humalog, its branded insulin product. The generic will cost $137 per vial, or half as much as Humalog. Lilly’s move is seen as a partial concession to lawmakers who have grilled pharma companies about the high cost of life-saving prescription drugs. But the company will keep Humalog at its current price. Why this two-tiered drug strategy?

Click the audio player above to hear the full story.

Related Topics

Latest Episodes

View All Shows
  • Marketplace Morning Report
    an hour ago
    6:57
  • Marketplace Tech
    6 hours ago
    5:47
  • Marketplace
    18 hours ago
    25:36
  • This Is Uncomfortable
    6 days ago
    42:59
  • Million Bazillion
    15 days ago
    29:48
  • Make Me Smart
    5 months ago
    24:33